Association of variants in estrogen-related pathway genes with prostate cancer risk

Prostate

Volumn 73, Issue 1, 2013, Pages 1-10

  Holt, Sarah K ^a   Kwon, Erika M ^b,c   Fu, Rong ^a,d   Kolb, Suzanne ^a   Feng, Ziding ^a,d   Ostrander, Elaine A ^b   Stanford, Janet L ^a,d  

^a Fred Hutchinson Cancer Research Center   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

aromatase; cytochrome P450; estrogen receptor; polymorphism; prostate neoplasm

Indexed keywords

AROMATASE; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; CLINICAL FEATURE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ARYL HYDROCARBON HYDROXYLASES; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; EPISTASIS, GENETIC; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 84870484459     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22534     Document Type: Article

References (30)

1. Huggins C, Hodges CV,. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1941; 19: 293-297.
2. Ho SM,. Estrogens and anti-estrogens: Key mediators of prostate carcinogenesis and new therapeutic candidates. J Cell Biochem 2004; 91 (3): 491-503.
3. Rhodes L, Ding VD, Kemp RK, Khan MS, Nakhla AM, Pikounis B, Rosner W, Saunders HM, Feeney WP,. Estradiol causes a dose-dependent stimulation of prostate growth in castrated beagle dogs. Prostate 2000; 44 (1): 8-18. (Pubitemid 30390060)
4. Prins GS, Korach KS,. The role of estrogens and estrogen receptors in normal prostate growth and disease. Steroids 2008; 73 (3): 233-244.
5. Bonkhoff H, Berges R,. The evolving role of oestrogens and their receptors in the development and progression of prostate cancer. Eur Urol 2009; 55 (3): 533-542.
6. Ellem SJ, Risbridger GP,. The dual, opposing roles of estrogen in the prostate. Ann N Y Acad Sci 2009; 1155: 174-186.
7. Bieche I, Narjoz C, Asselah T, Vacher S, Marcellin P, Lidereau R, Beaune P, de Waziers I,. Reverse transcriptase-PCR quantification of mRNA levels from cytochrome CYP1, CYP2 and CYP3 families in 22 different human tissues. Pharmacogenet Genomics 2007; 17 (9): 731-742. (Pubitemid 47263068)
8. Yager JD,. Endogenous estrogens as carcinogens through metabolic activation. J Natl Cancer Inst 2000; Monographs: 67-73.
9. Markushin Y, Gaikwad N, Zhang H, Kapke P, Rogan EG, Cavalieri EL, Trock BJ, Pavlovich C, Jankowiak R,. Potential biomarker for early risk assessment of prostate cancer. Prostate 2006; 66 (14): 1565-1571. (Pubitemid 44465821)
10. Berndt SI, Chatterjee N, Huang WY, Chanock SJ, Welch R, Crawford ED, Hayes RB,. Variant in sex hormone-binding globulin gene and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2007; 16 (1): 165-168. (Pubitemid 46174281)
11. Beuten J, Gelfond JA, Franke JL, Weldon KS, Crandall AC, Johnson-Pais TL, Thompson IM, Leach RJ,. Single and multigenic analysis of the association between variants in 12 steroid hormone metabolism genes and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2009; 18 (6): 1869-1880.
12. Chae YK, Huang HY, Strickland P, Hoffman SC, Helzlsouer K,. Genetic polymorphisms of estrogen receptors alpha and beta and the risk of developing prostate cancer. PLoS ONE 2009; 4 (8): e6523.
13. Chang BL, Zheng SL, Isaacs SD, Turner A, Hawkins GA, Wiley KE, Bleecker ER, Walsh PC, Meyers DA, Isaacs WB, Xu J,. Polymorphisms in the CYP1A1 gene are associated with prostate cancer risk. Int J Cancer 2003; 106 (3): 375-378. (Pubitemid 36870399)
14. Chang BL, Zheng SL, Isaacs SD, Turner A, Hawkins GA, Wiley KE, Bleecker ER, Walsh PC, Meyers DA, Isaacs WB, Xu J,. Polymorphisms in the CYP1B1 gene are associated with increased risk of prostate cancer. Br J Cancer 2003; 89 (8): 1524-1529. (Pubitemid 37386610)
15. Cunningham JM, Hebbring SJ, McDonnell SK, Cicek MS, Christensen GB, Wang L, Jacobsen SJ, Cerhan JR, Blute ML, Schaid DJ, Thibodeau SN,. Evaluation of genetic variations in the androgen and estrogen metabolic pathways as risk factors for sporadic and familial prostate cancer. Cancer Epidemiol Biomarkers Prev 2007; 16 (5): 969-978. (Pubitemid 46910099)
16. Nicolaiew N, Cancel-Tassin G, Azzouzi AR, Grand BL, Mangin P, Cormier L, Fournier G, Giordanella JP, Pouchard M, Escary JL, Valeri A, Cussenot O,. Association between estrogen and androgen receptor genes and prostate cancer risk. Eur J Endocrinol 2009; 160 (1): 101-106.
17. Stanford JL, Wicklund KG, McKnight B, Daling JR, Brawer MK,. Vasectomy and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 1999; 8 (10): 881-886. (Pubitemid 29508723)
18. Agalliu I, Salinas CA, Hansten PD, Ostrander EA, Stanford JL,. Statin use and risk of prostate cancer: Results from a population-based epidemiologic study. Am J Epidemiol 2008; 168 (3): 250-260. (Pubitemid 352019786)
19. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA,. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004; 74 (1): 106-120. (Pubitemid 38085242)
20. Chapman JM, Cooper JD, Todd JA, Clayton DG,. Detecting disease associations due to linkage disequilibrium using haplotype tags: A class of tests and the determinants of statistical power. Hum Hered 2003; 56 (1-3): 18-31. (Pubitemid 37465067)
21. Edgington ES, Onghena P,. Randomization tests. In:, Owen DB, editor. Statistics: Textbooks and Monographs, 4th edition. Boca Raton: Chapman & Hall/CRC; 2007.
22. Barrett JC, Fry B, Maller J, Daly MJ,. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics (Oxford, England) 2005; 21: 263-265. (Pubitemid 40202029)
23. Li SS, Khalid N, Carlson C, Zhao LP,. Estimating haplotype frequencies and standard errors for multiple single nucleotide polymorphisms. Biostatistics 2003; 4 (4): 513-522.
24. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC,. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81 (3): 559-575. (Pubitemid 47330214)
25. Yeager M, Orr N, Hayes RB, Jacobs KB, Kraft P, Wacholder S, Minichiello MJ, Fearnhead P, Yu K, Chatterjee N, Wang Z, Welch R, Staats BJ, Calle EE, Feigelson HS, Thun MJ, Rodriguez C, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Giovannucci E, Willett WC, Cancel-Tassin G, Cussenot O, Valeri A, Andriole GL, Gelmann EP, Tucker M, Gerhard DS, Fraumeni JF Jr, Hoover R, Hunter DJ, Chanock SJ, Thomas G,. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 2007; 39: 645-649. (Pubitemid 46676108)
26. Cussenot O, Azzouzi AR, Nicolaiew N, Fromont G, Mangin P, Cormier L, Fournier G, Valeri A, Larre S, Thibault F, Giordanella JP, Pouchard M, Zheng Y, Hamdy FC, Cox A, Cancel-Tassin G,. Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: The hidden face of estrogens. J Clin Oncol 2007; 25 (24): 3596-3602. (Pubitemid 47376605)
27. Chen YC, Kraft P, Bretsky P, Ketkar S, Hunter DJ, Albanes D, Altshuler D, Andriole G, Berg CD, Boeing H, Burtt N, Bueno-de-Mesquita B, Cann H, Canzian F, Chanock S, Dunning A, Feigelson HS, Freedman M, Gaziano JM, Giovannucci E, Sanchez MJ, Haiman CA, Hallmans G, Hayes RB, Henderson BE, Hirschhorn J, Kaaks R, Key TJ, Kolonel LN, LeMarchand L, Ma J, Overvad K, Palli D, Pharaoh P, Pike M, Riboli E, Rodriguez C, Setiawan VW, Stampfer M, Stram DO, Thomas G, Thun MJ, Travis RC, Virtamo J, Trichopoulou A, Wacholder S, Weinstein SJ,. Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev 2007; 16 (10): 1973-1981. (Pubitemid 47621170)
28. Travis RC, Schumacher F, Hirschhorn JN, Kraft P, Allen NE, Albanes D, Berglund G, Berndt SI, Boeing H, Bueno-de-Mesquita HB, Calle EE, Chanock S, Dunning AM, Hayes R, Feigelson HS, Gaziano JM, Giovannucci E, Haiman CA, Henderson BE, Kaaks R, Kolonel LN, Ma J, Rodriguez L, Riboli E, Stampfer M, Stram DO, Thun MJ, Tjonneland A, Trichopoulos D, Vineis P, Virtamo J, Le Marchand L, Hunter DJ,. CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev 2009; 18 (10): 2734-2744.
29. Thellenberg-Karlsson C, Lindstrom S, Malmer B, Wiklund F, Augustsson-Balter K, Adami HO, Stattin P, Nilsson M, Dahlman-Wright K, Gustafsson JA, Gronberg H,. Estrogen receptor beta polymorphism is associated with prostate cancer risk. Clin Cancer Res 2006; 12 (6): 1936-1941.
30. Holzbeierlein JM, McIntosh J, Thrasher JB,. The role of soy phytoestrogens in prostate cancer. Curr Opin Urol 2005; 15 (1): 17-22. (Pubitemid 40105520)